B. Braun Launches Introcan Safety® Deep Access IV Catheters

BETHLEHEM, Pa., Dec. 15, 2017 -- B. Braun Medical Inc. recently introduced the Introcan Safety^® Deep Access IV Catheters to its growing portfolio of products that help improve the success of peripheral intravenous PIV access. Longer peripheral catheters facilitate IV procedures involving ultrasound guidance, access to deeper veins, patients with difficult access, or for those who are overweight and obese.^{1, 2}

The Deep Access IV Catheters are designed to access deeper veins for difficult access patients with damaged or not visible or palpable superficial veins. They are also designed to reduce the risk of complications associated with accessing deeper veins.

“Hospitals seeking to improve peripheral intravenous access for difficult access patients also want to enhance the patient experience and reduce costs,” said Steve Weber, Director of Marketing for IV and Vascular Access Systems at B. Braun. “Difficult access patients may undergo multiple insertion attempts or end up with a more costly Peripherally Inserted Central Catheter. Longer peripheral catheters used under ultrasound guidance can help reduce costs, the number of insertions, and complications associated with a PICC or a central venous catheter.”¹

The Deep Access IV Catheters are made of polyurethane and are available in four longer-length configurations: 18GA x 2.5”, 20GA x 2.5”, 22GA x 2.5”, and 24GA x 1.25”.

The new Introcan Safety Deep Access IV catheters are visible under ultrasound³ and are designed to:

• Promote easy access: The unique design of a Back-cut Universal Bevel produces a precise tricuspid incision designed for more comfortable insertion. It also is designed for a wide variety of insertion angles for deep and superficial vascular access
• Extend catheter in-dwell: Polyurethane catheter material and longer-length catheters are associated with extending the duration of therapy.¹
• Prevent accidental needle sticks: The fully automatic passive safety shield requires no manual activation, cannot be bypassed, and prevents needle reinsertions.

About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap^® and CAPS^®.

Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise^® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.

¹ Stone, Phillip, RN, and Britt Meyer, MSN. “Ultrasound-guided Peripheral I.V. Access: Guidelines for Practice.”   American Nurse Today. N.p., Aug. 2013. Web. 05 June 2014.
² Elia, Fabrizio, M.D., Ferrari, Giovanni, M.D., Molino, Paola, M.D., Converso, Marcella, M.D., De Filippi, Giovanna, M.D., Milan, Alberto, M.D., Apra, Fanco, M.D. “Standard-length catheters vs long catheters in ultrasound-guided peripheral vein cannulation.” The American Journal of Emergency Medicine. 2012. Vol. 30.
³ (ETR#: NPAK-AKRJQV) Data on file.

Contact:

Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]